Products
Research Areas
COVID-19
Resources
Login
Quick Order
Cart
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Contact Us

Locations


Orders Processing,
Shipping & Receiving,
Warehouse

2 Shaker Rd Suites
B001/B101
Shirley, MA 01464


Production Lab

Floor 6, Suite 620
20700 44th Avenue W
Lynnwood, WA 98036

Telephone Numbers



Tel: +1 (206) 374-1102
Fax: +1 (206) 577-4565

Contact Us



Additional Contact Details

Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Catalog Number Size Price
LS-C58378-0.2 0.2 mg $486 
Antibody

Monoclonal Mouse anti‑Virus Rabies Virus Glycoprotein Antibody (clone 1C5, IHC, IF) LS‑C58378

Monoclonal Mouse anti‑Virus Rabies Virus Glycoprotein Antibody (clone 1C5, IHC, IF) LS‑C58378

Antibody:
Rabies Virus Glycoprotein Mouse anti-Virus Monoclonal (1C5) Antibody
Application:
IHC-Fr, IF, ELISA
Reactivity:
Virus
Format:
Unconjugated, Unmodified
Price
Catalog Number
$486
LS-C58378-0.2
Toll Free North America
206-374-1102
For Research Use Only

Overview

Antibody:
Rabies Virus Glycoprotein Mouse anti-Virus Monoclonal (1C5) Antibody
Application:
IHC-Fr, IF, ELISA
Reactivity:
Virus
Format:
Unconjugated, Unmodified

Specifications

Description
Rabies Virus Glycoprotein antibody LS-C58378 is an unconjugated mouse monoclonal antibody to virus Rabies Virus Glycoprotein. Validated for ELISA, IF and IHC.
Target
Rabies Virus Glycoprotein
Host
Mouse
Reactivity
Virus (tested or 100% immunogen sequence identity)
Clonality
IgG2a Monoclonal
Clone
1C5
Conjugations
Unconjugated
Purification
Affinity purified
Modifications
Unmodified
Immunogen
Purified rabies virus.
Specificity
Recognizes the glycoprotein of rabies virus, a Lyssavirus that causes rabies in mammals. The virus is found in the saliva of infected animals and is mostly spread though bites. The virus then travels though the peripheral nervous system to the central nervous system. Once it reaches the brain it causes acute encephalitis. Symptoms include paralysis, cerebral dysfunction, anxiety, insomnia, confusion, anger, paranoia, terror and hallucination. The production of a large amount of saliva, the inability to speak or swallow and associated hydrophobia is also common in the later stages of the disease. The time between exposure to the virus and onset of symptoms can range from about 2 weeks to several months. Once symptoms appear, death is virtually inevitable. However, the disease can be effectively treated by post-exposure prophylaxis, through vaccination, provided this is done as soon as possible. Recognizes the purified glycoprotein of the rabies virus as well as the native virus. It has been shown to react with intact infected BHK cells and has therapeutic effect on infected mice. The antibody has virus-neutralizing activity with several rabies virus strains such as CVS, Lagos bat, Mokola, Flury LEP and Duvenhage.
Applications
  • IHC - Frozen
  • Immunofluorescence
  • ELISA
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
Presentation
PBS, 0.09% Sodium Azide
Storage
Store at 4°C or at -20°C. Store undiluted. Avoid freeze-thaw cycles. Microcentrifugation recommended if solution contains precipitate.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee

Publications (0)

Customer Reviews (0)


Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at:

Technical.Support@LSBio.com

Requested From: United States
Date Requested: 4/18/2024